Abstract Background Risk stratification is an important step in perioperative evaluation. However, the main risk scores do not incorporate biomarkers in their set of variables. Objective Evaluate the incremental power of troponin to the usual risk stratification Methods A total of 2,230 patients admitted to the intensive care unit after non-cardiac surgery were classified according to three types of risk: cardiovascular risk (CVR), Revised Cardiac Risk Index (RCRI); and inherent risk of surgery (IRS). The main outcome was all-cause mortality. Cox regression was used as well as c-statistics before and after addition of high-sensitivity troponin (at least one measurement up to three days after surgery). Finally, net reclassification index and integrated discrimination improvement were used to assess the incremental power of troponin for risk stratification. Significance level was set at 0.05. Results Mean age of patients was 63.8 years and 55.6% were women. The prevalence of myocardial injury after non-cardiac surgery (MINS) was 9.4%. High CVR-patients had a higher occurrence of MINS (40.1 x 24.8%, p<0.001), as well as high IRS-patients (21.3 x 13.9%, p=0.004) and those with a RCRI≥3 (3.0 x 0.7%, p=0.009). Patients without MINS, regardless of the assessed risk, had similar mortality rate. The addition of troponin to the risk assessment improved the predictive ability of death at 30 days and at 1 year in all risk assessments. Conclusion The prevalence of MINS is higher in the high-risk population. However, its prevalence in lower-risk population is not negligible and causes a higher risk of death. The addition of high-sensitivity troponin increased the predictive ability of risk assessment in all groups. evaluation However variables 2230 2 230 2,23 noncardiac non cardiac CVR, CVR , (CVR) RCRI (RCRI) IRS. IRS . (IRS) allcause cause cstatistics c statistics highsensitivity sensitivity surgery. surgery) Finally 005 0 05 0.05 638 63 8 63. 556 55 6 55.6 women (MINS 94 9 4 9.4% CVRpatients 40.1 401 40 (40. 248 24 24.8% p<0.001, p0001 p p<0.001 001 p<0.001) IRSpatients 21.3 213 21 3 (21. 139 13 13.9% p=0.004 p0004 004 RCRI3 RCRI≥ 3.0 (3. 07 7 0.7% p=0.009. p0009 p=0.009 009 p=0.009) rate assessments highrisk lowerrisk lower groups 223 23 2,2 (CVR (RCRI (IRS 00 0.0 5 55. 9.4 40. (40 24.8 p000 p<0.00 21. (21 13.9 p=0.00 3. (3 0.7 22 2, 0. 9. (4 24. p00 p<0.0 (2 13. p=0.0 ( p0 p<0. p=0. p<0 p=0 p< p=

Resumo Fundamento A estratificação ode risco é uma importante etapa na avaliação perioperatória. No entanto, os principais escores de risco não incorporam biomarcadores em seus conjuntos de variáveis. Objetivo Avaliar o poder incremental da troponina à estratificação de risco tradicional. Métodos Um total de 2230 pacientes admitidos na unidade de terapia intensiva após cirurgia não cardíaca foram classificados de acordo com três tipos de risco: Risco Cardiovascular (RCV), Índice de Risco Cardíaco Revisado (IRCR), e Risco Inerente da Cirurgia (RIC). O principal desfecho foi mortalidade por todas as causas. A regressão de Cox foi usada, assim como a estatística C antes e após a adição de troponina ultrassensível (pelo menos uma medida até três dias após a cirurgia). Finalmente, o índice de reclassificação líquida e a melhoria de discriminação integrada foram usadas para avaliar o poder incremental da troponina para a estratificação de risco. O nível de significância usado foi de 0,05. Resultados A idade média dos pacientes foi 63,8 anos e 55,6% eram do sexo feminino. A prevalência de lesão miocárdica após cirurgia não cardíaca (MINS) foi 9,4%. Pacientes com um RCV elevado apresentaram uma maior ocorrência de MINS (40,1% x 24,8%, p<0,001), bem como pacientes com alto RIC (21,3 x 13,9%, p=0,004) e aqueles com IRCR≥3 (3,0 x 0,7%, p=0,009). Pacientes sem MINS, independentemente do risco avaliado, apresentaram taxa de mortalidade similar. A adição de troponina à avaliação de risco melhorou a capacidade preditiva de mortalidade em 30 dias e de mortalidade em um ano em todas as avaliações de risco. Conclusão A prevalência de MINS é mais alta na população de alto risco. No entanto, sua prevalência na população de risco mais baixo não é desprezível e causa um maior risco de morte. A adição da troponina ultrassensível melhorou a capacidade preditiva da avaliação de risco em todos os grupos. perioperatória entanto variáveis tradicional 223 RCV, , (RCV) IRCR, IRCR (IRCR) RIC. . (RIC) causas usada pelo cirurgia. cirurgia) Finalmente 005 0 05 0,05 638 63 8 63, 556 55 6 55,6 feminino (MINS 94 9 4 9,4% 40,1% 401 40 1 (40,1 248 24 24,8% p<0,001, p0001 p p<0,001 001 p<0,001) 21,3 213 21 3 (21, 139 13 13,9% p=0,004 p0004 004 IRCR3 IRCR≥ 3,0 (3, 07 7 0,7% p=0,009. p0009 p=0,009 009 p=0,009) avaliado similar morte grupos 22 (RCV (IRCR (RIC 00 0,0 5 55, 9,4 40,1 (40, 2 24,8 p000 p<0,00 21, (21 13,9 p=0,00 3, (3 0,7 0, 9, 40, (40 24, p00 p<0,0 (2 13, p=0,0 ( (4 p0 p<0, p=0, p<0 p=0 p< p=

Abstract The record of Mesozoic reptiles in the Northern region of Brazil is extremely limited, with the only definite occurrence consisting of two ziphodont teeth recovered from an oil well core in the municipality of Nova Olinda do Norte, Amazonas state, from strata of the Alter do Chão Formation (Cenomanian) of the Amazonas Basin. In this study, we aim to reevaluate MCT.R.514 using the most recent methodologies available for the identification of isolated theropod teeth. The cladistic analyses recovered MCT.R.514 as a possible metriacanthosaurid or non carcharodontosaurid allosauroid while the LDAs showed affinities between the specimen and Abelisauridae, Piatniktzysauridae, and Tyrannosauridae. MCT.R.514 was assigned as an abelisaurid due to its overall morphology that lacked metriacanthosaurid synapomorphies (i.e. spiraling mesial carina, strongly labially displaced distal carina, and well-marked mesiolingual longitudinal groove), while maintaining homoplastic features between both groups (i.e. irregular enamel texture, a lingually biconcave cross section, and a straight distal margin). This, together with a mostly Laurasian distribution of Metriacanthosauridae favors the assignment of MCT.R.514 as an abelisaurid as the most parsimonious hypothesis in this occasion. The identification of the specimen as an abelisaurid further expands the still scarce “Mid’’ Cretaceous record of this clade in Brazil. limited Norte state Cenomanian (Cenomanian Basin study MCTR514 MCTR MCT R 514 MCT.R.51 Abelisauridae Piatniktzysauridae Tyrannosauridae i.e. ie i e (i.e carina wellmarked marked groove, groove , groove) texture section margin. margin . margin) This occasion Mid “Mid’ MCTR51 51 MCT.R.5 i.e “Mid MCTR5 5 MCT.R. MCT.R

Abstract Background Literature is scarce on echocardiographic characteristics of COVID-19 patients admitted to the intensive care unit (ICU). Objectives To describe echocardiographic characteristics of ICU COVID-19 patients and associate them with clinical signals/symptoms, laboratory findings and outcomes. Methods Patients with RT-PCR-confirmed COVID-19, admitted to the ICU, who underwent echocardiography were included. Clinical characteristics associated with an abnormal echocardiogram (systolic ventricular dysfunction of any degree — left and/or right ventricle — and/or high filling pressures and/or moderate to severe pericardial effusion) were analyzed. Groups were compared using the Student’s t-test, chi-square, and logistic regression. A p < 0.05 was considered statistically significant. Results A total of 140 patients met inclusion criteria, and 74 (52.9%) had an abnormal echocardiogram. A low number of left and right ventricular systolic dysfunction was observed, and 35% of the population had a normal diastolic function. In the univariate analysis, characteristics associated with abnormal echocardiogram were age, chronic kidney disease, elevated troponin, previous heart failure, and simplified acute physiology score 3 (SAPS 3). In the regression model, troponin and SAPS3 score were independent markers of abnormal echocardiogram. An abnormal echocardiogram was associated with a higher prevalence of in-hospital death (RR 2.10; 95% CI 1.04-4.24) and orotracheal intubation (RR 2.3; 95% CI 1.14-4.78). Conclusions COVID-19 has little effect on ventricular function, but it is common to find increased filling pressures. Elevated serum troponin level and SAPS3 score were the independent markers of an abnormal echocardiogram. In addition, the prevalence of in-hospital death and need for mechanical ventilation were higher in patients with abnormal echocardiogram. COVID19 COVID 19 COVID-1 ICU. . (ICU) signalssymptoms signals symptoms signals/symptoms outcomes RTPCRconfirmed RT PCR confirmed COVID19, 19, included andor or effusion analyzed Students Student s ttest, ttest t test, test t-test chisquare, chisquare chi square, square chi-square 005 0 05 0.0 significant 14 criteria 7 52.9% 529 52 9 (52.9% observed 35 function analysis age disease failure SAPS 3. 3) model inhospital hospital RR 2.10 210 2 10 95 1.044.24 104424 1.04 4.24 1 04 4 24 1.04-4.24 2.3 23 1.144.78. 114478 1.14 4.78 78 1.14-4.78) addition COVID1 COVID- (ICU 00 0. 52.9 5 (52.9 2.1 21 044 1.044.2 10442 104 1.0 424 4.2 1.04-4.2 2. 144 1.144.78 11447 114 1.1 478 4.7 1.14-4.78 52. (52. 1.044. 1044 1. 42 4. 1.04-4. 1.144.7 1144 11 47 1.14-4.7 (52 1.044 1.04-4 1.144. 1.14-4. (5 1.04- 1.144 1.14-4 ( 1.14-

Resumo Fundamento Alguns estudos demonstraram uma maior prevalência de óbitos em portadores de fatores de risco cardiovascular (FRC) durante internação por COVID-19. Objetivos Avaliar o impacto do alto risco cardiovascular em pacientes internados em terapia intensiva por COVID-19 Métodos Estudo retrospectivo com pacientes admitidos em terapia intensiva, com diagnóstico confirmado de COVID-19 por RT-PCR e com pelo menos uma dosagem de troponina durante a internação. Os critérios para definição de paciente de alto risco cardiovascular (ARC) foram: histórico de doença cardiovascular estabelecida (infarto, AVC ou doença arterial periférica), diabetes, doença renal crônica com clearance < 60ml/min ou presença de 3 FRC (hipertensão, tabagismo, dislipidemia ou idade > 65 anos). O desfecho primário deste estudo é mortalidade hospitalar por todas as causas. P<0,05 foi considerado significativo. Resultados Foram incluídos 236 pacientes, média de idade= 61,14±16,2 anos, com 63,1% homens, 55,5% hipertensos e 33,1% diabéticos. Um total de 47,4% dos pacientes apresentavam ARC. Observou-se um aumento significativo da mortalidade conforme aumento do número de fatores de risco (0 FRC: 5,9%; 1 FRC: 17,5%; 2 FRC: 32,2% e ≥3 FRC: 41,2%; p=0,001). Na regressão logística ajustada para gravidade (escore SAPS3), o grupo de alto risco cardiovascular e troponina elevada apresentou maior ocorrência de mortalidade hospitalar (OR 40,38; IC95% 11,78-138,39). Pacientes sem alto risco cardiovascular, mas com troponina elevada, também exibiram associação significativa com o desfecho primário (OR 16,7; IC95% 4,45-62,74). Conclusão Em pacientes internados em terapia intensiva por COVID-19, a presença de alto risco cardiovascular afeta a mortalidade hospitalar somente em pacientes que apresentaram elevação de troponina.

Abstract Background Some studies have shown a higher prevalence of deaths in patients with cardiovascular risk factors (CRF) during hospitalization for COVID-19. Objectives To assess the impact of high cardiovascular risk in patients hospitalized in intensive care for COVID-19 Methods Retrospective study with patients admitted to an intensive care unit, with a diagnosis of COVID-19 confirmed by RT-PCR, and with at least one troponin measurement during hospitalization. The criteria for defining high cardiovascular risk (HCR) patients were: history of established cardiovascular disease (myocardial infarction, stroke, or peripheral arterial disease), diabetes, chronic kidney disease with clearance < 60ml/min, or presence of 3 CRFs (hypertension, smoking, dyslipidemia, or age > 65 years). The primary outcome of this study is all-cause in-hospital mortality. P<0.05 was considered significant. Results This study included 236 patients, mean age = 61.14±16.2 years, with 63.1% men, 55.5% hypertensive, and 33.1% diabetic; 47.4% of the patients also presented HCR. A significant increase in mortality was observed as the number of risk factors increased (0 FRC: 5.9%; 1 FRC: 17.5%; 2 FRC: 32.2% and ≥3 FRC: 41.2%; p=0.001). In the logistic regression adjusted for severity (SAPS3 score), the HCR and myocardial injury group had a higher occurrence of in-hospital mortality (OR 40.38; 95% CI 11.78-138.39). Patients without HCR but with myocardial injury also exhibited a significant association with the primary outcome (OR 16.7; 95% CI 4.45-62.74). Conclusion In patients hospitalized in intensive care for COVID-19, HCR impacts in-hospital mortality only in patients with myocardial injury.

ABSTRACT: Aim: This study aimed to report the clinical case of an immediate implant-supported rehabilitation in infected alveolar socket with buccal bone resorption and apical periodontitis in the teeth 42 and 43. Case Report: The patient was rehabilitated with implants associated with guided bone regeneration and immediate provisionalization. After 4 months, the custom molding was made in order to receive the metal-ceramic prosthesis. The follow-up lasted 24 months and there was no painful symptomatology, infection, implant mobility or marked peri-implant bone loss in this period. Conclusion: Therefore, the placement of immediate implants on fresh infected alveolar sockets is viable for the implant-supported rehabilitation.

RESUMO Objetivo: Avaliar a utilidade e o valor prognóstico da tonometria arterial periférica - hiperemia reativa em pacientes com sepse, e investigar a associação dos resultados deste exame com os níveis séricos de algumas moléculas inflamatórias. Métodos: Estudo prospectivo, realizado em uma unidade de terapia intensiva para pacientes adultos com 18 leitos. Os critérios de exclusão foram imunossupressão grave ou tratamento com antibióticos iniciado mais de 48 horas antes da avaliação. Aplicamos o exame de tonometria arterial periférica - hiperemia reativa quando da inclusão (dia 1) e no dia 3. Avaliamos os níveis de interleucina 6, interleucina 10, proteínas do grupo 1 de mobilidade alta e de ST2 solúvel no sangue obtido quando da inclusão. Resultados: Dos 79 pacientes incluídos, 17 (21,6%) tiveram os sinais da tonometria arterial periférica - hiperemia reativa considerados tecnicamente não confiáveis, tendo sido excluídos do estudo. Assim, incluímos na análise final 62 pacientes, que foram submetidos a 95 exames de tonometria arterial periférica - hiperemia reativa dentro das primeiras 48 horas após sua inclusão. A média de idade foi de 51,5 (DP: 18,9), e 49 (62%) dos pacientes eram do sexo masculino. Os índices de hiperemia reativa dos dias 1 e 3 não se associaram com necessidade de vasopressores, SOFA, APACHE II ou mortalidade aos 28 dias. Dentre os pacientes que morreram, em comparação aos sobreviventes, houve aumento significante nos índices de hiperemia reativa no dia 3 em comparação ao dia 1 (p = 0,0045). Ocorreu fraca correlação negativa entre o índice obtido por tonometria arterial periférica - hiperemia reativa no dia 1 e os níveis de proteínas do grupo 1 de mobilidade alta (r = -0,287). Conclusão: Dificuldades técnicas e falta de associações claras dos resultados do exame com a gravidade clínica e com o desfecho foram fortes limitantes da utilidade do exame de tonometria arterial periférica - hiperemia reativa em pacientes sépticos admitidos à unidade de terapia intensiva.

ABSTRACT Objective: To evaluate the usefulness and prognostic value of reactive hyperemia - peripheral arterial tonometry in patients with sepsis. Moreover, we investigated the association of reactive hyperemia - peripheral arterial tonometry results with serum levels of certain inflammatory molecules. Methods: Prospective study, conducted in an 18-bed mixed intensive care unit for adults. The exclusion criteria included severe immunosuppression or antibiotic therapy initiated more than 48 hours before assessment. We measured the reactive hyperemia - peripheral arterial tonometry on inclusion (day 1) and on day 3. Interleukin-6, interleukin-10, high-mobility group box 1 protein and soluble ST2 levels were measured in the blood obtained upon inclusion. Results: Seventeen of the 79 patients (21.6%) enrolled were determined to have reactive hyperemia - peripheral arterial tonometry signals considered technically unreliable and were excluded from the study. Thus, 62 patients were included in the final analysis, and they underwent a total of 95 reactive hyperemia - peripheral arterial tonometry exams within the first 48 hours after inclusion. The mean age was 51.5 (SD: 18.9), and 49 (62%) of the patients were male. Reactive hyperemia indexes from days 1 and 3 were not associated with vasopressor need, Sequential Organ Failure Assessment score, Acute Physiology and Chronic Health Evaluation II score, or 28-day mortality. Among the patients who died, compared with survivors, there was a significant increase in the day 3 reactive hyperemia index compared with day 1 (p = 0.045). There was a weak negative correlation between the day 1 reactive hyperemia - peripheral arterial tonometry index and the levels of high-mobility group box 1 protein (r = -0.287). Conclusion: Technical difficulties and the lack of clear associations between the exam results and clinical severity or outcomes strongly limits the utility of reactive hyperemia - peripheral arterial tonometry in septic patients admitted to the intensive care unit.